DesiCorp
- Company typePrivate
- Founded2018
- HeadquartersLouisville, United States
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
DesiCorp firmographics
Firmographics- Name
- DesiCorp
- Legal name
- DesiCorp, Inc.
- Website
- https://desicorpinc.com
- Company type
- Private
- Founded year
- 2018
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Ownership category
- akta.pro rank
DesiCorp industry classification
Industry- Product category
- Blood Products & Biopreservation Technology
- NAICS
- Biological Product (except Diagnostic) Manufacturing (325414), Pharmaceutical Preparation Manufacturing (325412)
- SIC
- Biological Products, (No Disgnostic Substances) (2836)
- akta.pro primary industry
- Primary Pharmaceutical Packaging (Blister Packs, Bottles, Vials, Ampoules) (IMALAIAA)
- akta.pro secondary industry
- Sterile & Aseptic Medical Packaging (Pouches, Wraps, Sterile Barriers) (IMALAIAB)
Keywords
Where DesiCorp is headquartered
LocationHeadquarters
- HQ city
- Louisville
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
DesiCorp business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Technology or R&D, Operations, Supply Chain, Marketing or Sales, Infrastructure
Revenue model
- Medical Product Sales: DesiCorp generates revenue through the sale of stabilized medical products including freeze-dried therapeutics and blood products. The company sells shelf-stable medical products designed for use in challenging environments without refrigeration infrastructure.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels2 records
DesiCorp product offering
Product offeringCore offering
DesiCorp develops and sells freeze-dried (lyophilized) red blood cells and other sensitive therapeutics that are shelf-stable without refrigeration, paired with proprietary two-chambered packaging that enables safe, on-demand rehydration at the point of care. The company also produces advanced barrier materials (films, plastics, ceramics, coatings) that protect medical products in austere environments, and targets institutional healthcare buyers such as EMS providers, rural clinics, remote field operators, and hospitals.
Product overview
DesiCorp is a medical technology company offering an integrated portfolio of three interconnected solutions: Life Sciences technology for preserving sensitive compounds and therapeutics without refrigeration, Packaging Solutions featuring advanced two-chambered bags for dry therapeutics and rehydration fluids, and Advanced Materials including glasses, ceramics, plastics, films, and coatings. Together, these products enable medical products to be delivered, used, and trusted in challenging environments by extending shelf-life, eliminating cold chain requirements, and providing durable protective packaging.
Differentiator
Problem solved
Functional benefit
Companies that use DesiCorp
Customer profileSegments4 records
Ideal customer profiles3 records
DesiCorp technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
DesiCorp partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Safi Biotherapeutics Inc.coreDesiCorp and Safi Biotherapeutics Inc. have initiated a collaboration to develop freeze-dried human red blood cells (mRBCs) for portable, shelf-stable transfusions. This partnership aims to address critical shortages in blood supply and expand access to life-saving transfusions outside traditional hospital settings. The collaboration leverages DesiCorp's core competencies in life sciences, packaging solutions, and advanced materials with Safi Biotherapeutics' biotherapeutics capabilities.
Scale indicators1 record
Recent moves5 records
Expansion highlights5 records
DesiCorp competitors and assessment
Company assessmentDirect peers
- Safi Biotherapeutics Inc. Co-development partner on freeze-dried human red blood cells (mRBCs). Operates in the same shelf-stable blood product category and brings complementary biotherapeutics capabilities that DesiCorp is leveraging under their 2026 collaboration.
- Velico Medical: Develops spray-dried plasma and other dried, shelf-stable blood products using proprietary dehydration technology. Directly comparable in mission (eliminating cold chain for transfusion medicine) and customer base (military, EMS, hospitals).
- Entegrion, Inc. Develops dried plasma and other stabilized blood products for battlefield, disaster, and trauma use. Comparable in shelf-stable blood product focus and target customers (military, EMS, austere environment medicine).
Broad incumbents
- Cerus Corporation: Public company (CERS) commercializing INTERCEPT, a pathogen-reduction system for platelets and plasma. Comparable as an established player in blood product safety/preservation, addressing the same transfusion medicine market through a different (additive) technology approach.
- Haemonetics Corporation: Public company (HAE) and established leader in blood component processing equipment and disposables used by blood banks and hospitals. Overlaps as a broad incumbent in the transfusion medicine supply chain that DesiCorp would need to integrate with or displace.
- Terumo BCT: Division of Terumo Corporation providing blood collection, processing, and storage technologies globally. Comparable as a broad incumbent shaping blood banking infrastructure; potential partner or competitor depending on adoption dynamics.
- Grifols, S.A. Global biotherapeutics major with a large plasma and blood products franchise (plasma-derived therapies, transfusion diagnostics). Comparable as an incumbent supplier in the broader blood/plasma therapeutics space.
Emerging players
- New Health Sciences (HemaNext): Developed HemaNext, a blood storage system designed to extend the shelf life of red blood cells through oxygen-reduction storage bags. Comparable focus on extending RBC shelf life and reducing blood product waste, though via storage technology rather than lyophilization.
- Hemerus Medical, LLC: Develops blood products and additive solutions for red cell and platelet storage. Adjacent in mission—improving blood product quality and shelf life—although focused on liquid storage solutions rather than freeze-drying.
Others
- Cook Medical: Privately held medical device manufacturer with extensive vascular and hospital product lines. Relevant as a comparable advanced-materials and medical packaging supplier, though broader in scope than DesiCorp's core blood/therapeutic focus.
Market position
Strengths1 record
Weaknesses5 records
Competitive moat3 records
Key risks5 records
Key highlights6 records
Customer concentration
DesiCorp financial estimates
Financial estimateRevenue estimate
Valuation estimate
DesiCorp leadership team
Management profileNumber of profiles
Profiles3 records
DesiCorp funding detail
Funding detailFunding overview
Funding rounds3 records
Investors2 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
DesiCorp M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about DesiCorp
What does DesiCorp do?
DesiCorp develops and sells freeze-dried (lyophilized) red blood cells and other sensitive therapeutics that are shelf-stable without refrigeration, paired with proprietary two-chambered packaging that enables safe, on-demand rehydration at the point of care. The company also produces advanced barrier materials (films, plastics, ceramics, coatings) that protect medical products in austere environments, and targets institutional healthcare buyers such as EMS providers, rural clinics, remote field operators, and hospitals.
Is DesiCorp a public or private company?
DesiCorp is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was DesiCorp founded?
DesiCorp was founded in 2018. It employs 1 to 10 people.
Where is DesiCorp based?
DesiCorp is headquartered in Louisville, United States, in the North America region.
How does DesiCorp make money?
One revenue line is on record: medical Product Sales.
Who are DesiCorp's main competitors?
Direct peers on record are Safi Biotherapeutics Inc., Velico Medical and Entegrion, Inc.. Broad incumbents are Cerus Corporation, Haemonetics Corporation, Terumo BCT and Grifols, S.A.. Emerging players are New Health Sciences (HemaNext) and Hemerus Medical, LLC. Cook Medical is listed as an others.
Does DesiCorp have an API?
No public API is recorded for DesiCorp.
What industry is DesiCorp in?
DesiCorp's product category is Blood Products & Biopreservation Technology. Its primary akta.pro industry code is IMALAIAA, Primary Pharmaceutical Packaging (Blister Packs, Bottles, Vials, Ampoules), with a secondary code of IMALAIAB, Sterile & Aseptic Medical Packaging (Pouches, Wraps, Sterile Barriers). Its NAICS code is 325414 and its SIC code is 2836.